NICHOLAS SIMPSON: Open Payments
NPI 1174174775 · ST. LOUIS, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,752 in 130 payments from 23 companies in 2025. Trend: 2023 $3,213 · 2024 $3,478 · 2025 $2,752
Food & beverage: $2,675Education: $77
| Company | Payments | Amount |
|---|---|---|
| UCB, Inc. | 25 | $635 |
| ABBVIE INC. | 15 | $398 |
| Janssen Biotech, Inc. | 10 | $257 |
| AstraZeneca Pharmaceuticals LP | 12 | $238 |
| Amgen Inc. | 9 | $208 |
| Novartis Pharmaceuticals Corporation | 18 | $178 |
| PFIZER INC. | 13 | $174 |
| ViiV Healthcare Company | 7 | $156 |
| GENZYME CORPORATION | 4 | $151 |
| Theratechnologies Inc. | 2 | $56 |
Products named: Bimzelx, RINVOQ, TREMFYA, SAPHNELO, XELJANZ, COSENTYX, KEVZARA, OTEZLA.
Industry payments across MO — which companies pay providers there.
